Allarity Therapeutics, Inc. balance sheet

At the end of fiscal 2025, Allarity Therapeutics, Inc. had total assets of $18.3m, total liabilities of $8.4m and shareholders' equity of $9.8m. It held $14.7m in cash against $1.4m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Allarity Therapeutics, Inc.: balance sheet, annual
Fiscal year	2024Dec 2024	2025Dec 2025
Cash and equivalents	20	15
Total current assets	22	18
Total assets	23	18
Accounts payable	4	4
Total current liabilities	11	8
Short-term debt	—	0
Total debt	3	1
Total liabilities	11	8
Shareholders' equity	12	10
Shares outstanding	—	16m

US$ millions unless shown otherwise. Fiscal quarters.

Allarity Therapeutics, Inc.: balance sheet, quarterly
Quarter	2025 Q1Mar 2025	2025 Q2Jun 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Total current assets	29	21	35	32
Total assets	30	21	35	32
Accounts payable	4	5	4	4
Total current liabilities	11	9	28	29
Short-term debt	—	—	20	21
Total debt	—	—	20	21
Total liabilities	11	9	28	29
Shareholders' equity	19	12	7	4
Shares outstanding	17m	15m	16m	16m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Allarity Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Allarity Therapeutics, Inc.